Cannabis Round-Up: Curaleaf Announces TSX Listing, Health Canada Shares Findings Cannabis Investing News
Wholly-Owned Subsidiary Halucenex Life Sciences Inc. Achieves Remission In 80% Of First Five Patients In Phase II Clinical Trial Cannabis Investing News
ECS Botanics Secures a $24 Million Offtake Agreement with MediCann Health for Supply of Medicinal Cannabis Cannabis Investing News
Melodiol Subsidiary Mernova Medicinal Inc. Scales Up As Q3 Sales Momentum Accelerates Cannabis Investing News
